Skip to content

AMPsy

Active
Private limited company·Activiteiten op het gebied van psychologie· 5 yrs active
Route de Bonsgnée(RR) 122 ·4120 Neupré, Belgium
BE 0770.677.371
Watch Print / PDF
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of AMPsy is 0.2% (very low). The 2025 annual accounts show equity of €25k and a net result of €29k. Equity is growing by ~33.4% per year across the filed fiscal years. Its solvency ranks better than 30% of 2200 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

1 signal · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Trust signals

3 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€29k+22.6%
Working capital€3k-94.0%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 01-06-2026 with the NBB · fiscal year 2025 · micro
€0€20k€40kOperating result 2022: €15k€15kNet result 2022: €12k€12kOperating result 2023: €29k€29kNet result 2023: €22k€22kOperating result 2024: €31k€31kNet result 2024: €24k€24kOperating result 2025: €41k€41kNet result 2025: €29k€29k2022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~33.4%/year over 4 fiscal years, indicative, assuming unchanged policy.
€0€50k€100k€150k2026: €74k (€53k - €95k)2027: €86k (€53k - €119k)2028: €97k (€52k - €143k)2022: €22k2023: €45k2024: €69k2025: €25k2022202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 21.4% 57.9%
better than 30% of 2200 sector peers
Net result €29k €60k
better than 28% of 2198 sector peers
Equity €25k €74k
better than 30% of 2200 sector peers
Gross operating margin €48k €96k
better than 26% of 2200 sector peers
Total assets €116k €186k
better than 32% of 2200 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P30
2022: P81 · n=36522023: P45 · n=53132024: P62 · n=65542025: P30 · n=22002022 2025
Weakening position over 2022-2025 · n=2200-6554
Net result P28
2022: P24 · n=36502023: P36 · n=53122024: P32 · n=65482025: P28 · n=21982022 2025
Stable position over 2022-2025 · n=2198-6548
Equity P30
2022: P26 · n=36522023: P39 · n=53152024: P46 · n=65542025: P30 · n=22002022 2025
Improving position over 2022-2025 · n=2200-6554
Gross operating margin P26
2022: P17 · n=36482023: P30 · n=53092024: P27 · n=65562025: P26 · n=22002022 2025
Stable position over 2022-2025 · n=2200-6556
Describes the position versus peers, not a forecast.
EBITDA
€48k
+23.8% 22-25
Net profit
€29k
+22.6% 22-25
Cash flow
€36k
+16.7% 22-25
Total assets
€116k
+27.5% 22-25
Equity
€25k
-63.9% 22-25
Working capital
€3k
-94.0% 22-25
Income taxes
€11k
+63.2% 22-25
Dividends
€73k
- 22-25
Debt
€91k
+311.3% 22-25
Debt ≤ 1y
€84k
+660.3% 22-25
Debt > 1y
€7k
-40.0% 22-25
Current ratio
1.03
-79.2% 22-25
Quick ratio
1.03
-79.2% 22-25
Solvency
21.4%
-71.7% 22-25
Debt / equity
3.67
+1040.2% 22-25
ROE
118.3%
+239.9% 22-25
ROA
25.3%
-3.8% 22-25
Interest coverage
83.73
+45.4% 22-25
Figures by fiscal year
Fiscal year2025
Revenue-
EBITDA€48k
Net profit€29k
Cash flow€36k
Staff costs-
Income taxes€11k
Dividends€73k
Total assets€116k
Equity€25k
Debt€91k
of which ≤ 1y€84k
of which > 1y€7k
Working capital€3k
Employees (FTE)-
Ratios (computed)
2025
Current ratio1.03
Quick ratio1.03
Working capital ratio2.3%
Solvency21.4%
Debt / equity3.67
Long-term debt ratio0.27
Interest coverage83.73
Gross margin-
Net margin-
ROA25.3%
ROE118.3%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€116k
Fixed assets 21/28€29k
Tangible fixed assets 22/27€28k
Financial fixed assets 28€336
Current assets 29/58€87k
Amounts receivable within one year 40/41€4k
Cash & bank 54/58€81k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€116k
Equity 10/15€25k
Contributions / capital 10/11€10k
Accumulated profits (losses) 14€15k
Amounts payable 17/49€91k
Amounts payable after one year 17€7k
Amounts payable within one year 42/48€84k
Trade debts payable within one year 44€5
Income statement
Gross operating margin 9900€48k
Operating result 9901€41k
Financial income 75€190
Financial charges 65€571
Result before taxes 9903€40k
Income taxes 67/77€11k
Net result for the period 9904€29k
Result to be appropriated 9905€29k
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
73 / 100 Healthy
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
AMPsy
Route de Bonsgnée(RR) 122, 4120 NeupréActiviteiten op het vlak van geestelijke gezondheidszorg, m.u.v. psychiatrische ziekenhuizen en verzorgingstehuizen
since 20212.319.127.270
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area517 m²

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62090D0355/00F000 Wallonia 517 m² - -
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health73Profitability100Solvency29Growth78Stability94
75 / 100

Exceptional profile, strong across almost every axis.

Health 73
Profitability 100
Solvency 29
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Activiteiten op het vlak van geestelijke gezondheidszorg, m.u.v. psychiatrische ziekenhuizen en verzorgingstehuizen86904Activiteiten op het gebied van psychologie86931
Primary activity highlighted.
Names & trade names
Legal nameFR AMPsy
Registered office
Route de Bonsgnée(RR) 122 bus B
4120 Neupré, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.